Outsourced Pharma Webinars

  1. Design Verification Done Right: Smarter Strategies For Prefillable Syringes 9/29/2026

    A practical framework for planning and justifying design verification programs for prefillable syringes, covering test selection, acceptance criteria, and sample-size rationale within a risk-based approach.

  2. IND In As Little As 6 Months: Now Beyond mAbs - Accelerating Bispecifics, Fc-Fusions And High-Concentration Biologics To The Clinic 9/25/2026

    Listen as our experts outline expanded accelerated DNA-to-IND pathways for a broader range of biologic modalities, examining how expression technologies and integrated CMC strategies can shorten development timelines.

  3. Scaling Cell And Gene Therapy Manufacturing 9/25/2026

    Artificial intelligence is reshaping healthcare. Discover proven strategies for secure, compliant AI adoption, strong data governance, and seamless integration to improve patient outcomes.

  4. Mastering The Path: Developing Processes For Successful Clinical-Grade mRNA Manufacturing 9/23/2026

    Discover strategies to optimize mRNA manufacturing, improve yield and full-length products, and enable scalable production of mRNA and saRNA therapies.

  5. De-Risking The Path To GMP Manufacturing At Another Organization 9/23/2026

    Successful tech transfer depends on more than moving a process. Early alignment across process readiness, analytical strategy, governance, and decision-making helps reduce execution risk.

  6. Breaking The Concentration Barrier: New Long-Term Stability And PK Data For Subcutaneous Nanotrastuzuma 9/22/2026

    Nanoparticle engineering enabled a 440 mg/mL trastuzumab suspension that clears viscosity and stability barriers limiting conventional high-dose subcutaneous biologics formulations.

  7. Unlocking Challenging Targets With Macrocycle DNA-Encoded Libraries 9/22/2026

    Discover how macrocycle DNA-encoded libraries can uncover new opportunities for challenging targets and help researchers translate promising screening hits into starting points for drug discovery.

  8. Breaking The AAV Titer Barrier: A 9x Manufacturing Breakthrough 9/22/2026

    See how targeted optimization of cell culture media and transfection reagents increased AAV titers ninefold while improving full capsid percentages, strengthening HEK293 production, and more.

  9. Beyond The Starting Material: A Path To GMP Manufacturing Success 9/21/2026

    Explore how starting material decisions affect cell therapy development, tech transfer, and GMP readiness, as well as practical guidance for aligning material requirements with manufacturing processes.

  10. Building Oral Dosage Forms for Speed Today And Success Tomorrow 9/18/2026

    Move toward the clinic with confidence using integrated development strategies that support smarter decisions and more efficient product development.